Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Adial Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 23 | 0 |
| Shares | 1.68M | 2.51M | +831.5K (+49.5%) |
| Value | $359.2K | $876.9K | +$517.7K (+144.1%) |
New holders (2)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Manchester Capital Management LLC | 1,202,452 | $420.9K | 0.06% |
| Envestnet Asset Management Inc | 13,088 | $4.58K | 0.00% |
Sold out (2)
Institutions that held Adial Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HRT Financial LP | 31,291 | $6.00K |
| Group One Trading, L.P. | 200 | $43 |